The journal retracts the 2020 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. An investigation by our internal Research Integrity department, conducted in accordance with Frontiers policies, was unable to confirm the validity of the data presented and we cannot vouch for its reliability. The article is therefore retracted.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.
Summary
Citation
Frontiers Editorial Office (2024) Retraction: Mir-124 attenuates STAT3-mediated TH17 differentiation in colitis-driven colon cancer. Front. Oncol. 14:1506202. doi: 10.3389/fonc.2024.1506202
Received
04 October 2024
Accepted
04 October 2024
Published
17 October 2024
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
14 - 2024
Updates
Copyright
© 2024 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.